What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Genetic variations in testosterone receptor predispose to severe COVID-19 in men The researchers found that the presence of a high number of repeats of a specific amino acid in the testosterone receptor is related to a worse clinical course of COVID-19. News Vall d'Hebron leads a study to improve the treatment of lysosomal disorders The VHIR develops extracellular vesicles as vehicles for therapeutic enzymes in lysosomal storage disorders. News A study demonstrates the effectiveness of a multicomponent treatment for patients with fibromyalgia The Rheumatology research group has participated in the FIBROWALK study. News The BCN-PID Foundation makes a new donation of €30,000 to Vall d’Hebron for the research on primary immunodeficiencies This donation allows the hiring of a research coordinator in the Infection in Immunocompromised Pediatric Patients group at the VHIR. News Dr. Carlos Molina receives the Spirit of Excellence Award that recognizes his commitment to the stroke patient The award highlights the efforts of the Vall d'Hebron Stroke Unit to care for patients with stroke in times of pandemic and the ability to innovate of Dr. Molina and his team. News The Clinical Research Ethics Committee in Vall d’Hebron, the most active in the State During 2020, it evaluated 105 clinical trials proposals, the highest number in Spain for the fifth consecutive year. News Published the results of the Vall d’Hebron study, which shows that minors are low transmitters of SARS-CoV-2 Only 7.7% of pediatric patients with COVID-19 transmitted the SARS-CoV-2 infection to the rest of their family members. News Vall d’Hebron develops synthetic erythrocytes that would help global control of influenza viruses This new tool would facilitate pathogen surveillance and vaccine production control. News Dr. Marta Vila rejoins the Research Group in Headache in Vall d’Hebron thanks to a Marie Skłodowska-Curie grant The aid is valued at euros172,932.48 for two years and will enable to establish a new line of research to study the migraine brain in animal models. News Today, we celebrate the International Day of Women We review the numbers of women working at the VHIR. The VHIR currently employs 1,362 people, of whom 795, or 58%, are women. News Vall d’Hebron promotes research against women’s cancer with the fourth edition of the ‘Solidarity Kerchief’ All the profits raised will be used to finance research in women's cancer by two researchers from the Vall d'Hebron Research Institute (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO). News Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR Simó Schwartz now assumes the executive management of the organization of the Blood and Tissue Bank, which currently has more than 800 workers, and is a reference centre in diagnostic immunology and in the development of advanced therapies. News El Dr. Xavier Muñoz, investigador principal del grup de recerca en Pneumologia del VHIR i adjunt del Servei de Pneumologia de l’Hospital, ha estat reconegut Ripollès de l’Any 2020 El premi reconeix la seva tasca a l'Hospital en la lluita contra l'epidèmia i l'estudi que està impulsant sobre les seqüeles de la COVID-19. News Vall d'Hebron hosts an exhibition that highlights the role of scientific women Twenty-four women inspire future researchers in the traveling exhibition "Catalan Women Scientists 2.0". Dr. Ariadna Laguna, from VHIR, and Dr. Laura Soucek, from VHIO, are some of the protagonists of this exhibition, which aims to disseminate female roles in the fields of science and engineering. News Vall d'Hebron, a benchmark in rare diseases February 28 is the World Day of minority diseases, a day to raise awareness about this broad set of pathologies that affects between 5% and 7% of the population. News Vall d'Hebron participates in a study to improve the treatment of Fabry disease using nanoparticles The study, along with others that have not yet been published, has led to the Orphan Drug Designation for this type of liposomes, which provides incentives to stimulate research and development of new drugs. News Dr. Joan X. Comella and Laia Arnal participate in the creation of a book on health innovation and covid-19 The chapter "Science and innovation in the university hospital of the 21st century" analyzes the role of hospitals as centers of transformation, innovation and social and economic development. News The activation of an immune system cell type would facilitate the elimination of HIV infection A study led by Vall d'Hebron has shown, thanks to the use of gold nanoparticles and cell cultures, that enhancing the activity of natural killer cells of the immune system is key to eliminating HIV infection. News Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer This clinical study represents the final stage of the NoCanTher project, in which professionals across different fields from eleven national and international research centers are involved. News A study by Vall d'Hebron suggests a new strategy for the treatment of colorectal cancer The VHIR participates in a study with the aim of finding a useful treatment to combat colorectal cancer, but also to eradicate cancer stem cells. Pagination First page « Previous page ‹ … Page 56 Page 57 Current page 58 Page 59 Page 60 … Next page › Last page »
